Activation of cellular stress response pathways to maintain metabolic homeostasis is emerging as a critical growth and survival mechanism in many cancers 1 . The pathogenesis of pancreatic ductal adenocarcinoma (PDA) requires high levels of autophagy [2][3][4] , a conserved self-degradative process 5 . However, the regulatory circuits that activate autophagy and reprogram PDA cell metabolism are unknown. Here we show that autophagy induction in PDA occurs as part of a broader transcriptional program that coordinates activation of lysosome biogenesis and function, and nutrient scavenging, mediated by the MiT/TFE family of transcription factors. In human PDA cells, the MiT/TFE proteins 6 -MITF, TFE3 and TFEB-are decoupled from regulatory mechanisms that control their cytoplasmic retention. Increased nuclear import in turn drives the expression of a coherent network of genes that induce high levels of lysosomal catabolic function essential for PDA growth. Unbiased global metabolite profiling reveals that MiT/ TFE-dependent autophagy-lysosome activation is specifically required to maintain intracellular amino acid pools. These results identify the MiT/TFE proteins as master regulators of metabolic reprogramming in pancreatic cancer and demonstrate that transcriptional activation of clearance pathways converging on the lysosome is a novel hallmark of aggressive malignancy.
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. The pathogenesis of pancreatic ductal adenocarcinoma (PDA) requires high levels of autophagy [2] [3] [4] , a conserved self-degradative process 5 . However, the regulatory circuits that activate autophagy and reprogram PDA cell metabolism are unknown. Here we show that autophagy induction in PDA occurs as part of a broader transcriptional program that coordinates activation of lysosome biogenesis and function, and nutrient scavenging, mediated by the MiT/TFE family of transcription factors. In human PDA cells, the MiT/TFE proteins 6 -MITF, TFE3 and TFEB-are decoupled from regulatory mechanisms that control their cytoplasmic retention. Increased nuclear import in turn drives the expression of a coherent network of genes that induce high levels of lysosomal catabolic function essential for PDA growth. Unbiased global metabolite profiling reveals that MiT/ TFE-dependent autophagy-lysosome activation is specifically required to maintain intracellular amino acid pools. These results identify the MiT/TFE proteins as master regulators of metabolic reprogramming in pancreatic cancer and demonstrate that transcriptional activation of clearance pathways converging on the lysosome is a novel hallmark of aggressive malignancy.
Autophagy delivers cargo to lysosomes for degradation, suggesting the possibility that these systems may be coordinately regulated in PDA. Immunostaining for LC3 and LAMP2 revealed significant expansion of both organelles in PDA cell lines compared with nontransformed human pancreatic ductal epithelial cells (HPDEs) (Fig. 1a and Extended Data Fig. 1a) . Notably, transmission electron microscopy demonstrated an increase in lysosome number per cell in treatment-naive PDA specimens relative to normal pancreatic tissue (12.6 6 4.3 versus 1.0 6 0.9; Fig. 1b) . Thus, increased lysosomal biogenesis accompanies the expanded autophagosome compartment in PDA and may facilitate high levels of autophagic flux. Consistent with transcriptional control of these organellar changes, gene set enrichment analysis (GSEA) of multiple independent data sets revealed that human PDA specimens have elevated expression of autophagy-lysosome genes compared with normal pancreatic tissue (Fig. 1c, Extended Data Fig. 1b and Supplementary Tables 1, 2) . Accordingly, immunohistochemistry confirmed upregulation of autophagy-lysosome proteins in the tumour epithelium (Fig. 1d) .
In normal cells exposed to nutrient stress, the biogenesis of both organelles is under transcriptional regulation by the MiT/TFE subclass of basic helix-loop-helix transcription factors [6] [7] [8] [9] [10] [11] . RNAsequencing (RNA-seq) data across ten common solid tumour types revealed high relative expression of these factors in PDA, with levels only exceeded in melanoma and kidney cancers, in which MiT/TFE transcription factors are established oncogenes (Extended Data   Fig. 1c ). Immunohistochemistry demonstrated overexpression of nuclear-localized TFE3 in the neoplastic epithelium in a subset of PDA (staining scores $2 in 23% of PDA versus 3% of normal pancreas specimens; P , 0.001) ( Fig. 1e and Extended Data Fig. 1d ; see Methods). Similarly, microdissected specimens and xenografts exhibited frequent upregulation of TFEB and MITF messenger RNA in PDA cells relative to normal ductal epithelium, and subsets of PDA cell lines showed MiT/TFE overexpression compared with HPDE cells (Extended Data Fig. 1e-h ). Generally, a single MiT/TFE family member predominated in individual specimens.
GSEA of human primary PDA data sets and cultured PDA cell lines showed strong correlation between expression of MiT/TFE factors and the autophagy-lysosome signature ( Fig. 1f and Extended Data Fig. 1i-k) . Accordingly, knockdown of TFE3 in the 8988T PDA cell line (TFE3-high, TFEB/MITF-low) resulted in prominent repression of this signature (global RNA-seq; Fig. 1g, h ). Chromatin immunoprecipitation (ChIP) confirmed that MITF and TFE3 bound to multiple autophagy and lysosome genes bearing a consensus coordinated lysosomal expression and regulation (CLEAR) element 7, 8 in PDA cells (Extended Data Fig. 2a) . Moreover, knockdown of MITF, TFE3 or TFEB caused downregulation of numerous CLEAR-bearing genes in a series of PDA cell lines with high relative expression of that MiT/TFE family member, whereas no significant changes were seen in nontransformed pancreatic lines (HPDE and HPNE) or in a pancreatic neuroendocrine tumour cell line (QGP1) (Extended Data Fig. 2b-d) . Expression of RNA interference (RNAi)-resistant MITF or TFE3 complementary DNA restored target gene expression whereas dominantnegative MITF recapitulated the effects seen with RNAi (Extended Data Fig. 2e, f) . Thus, MiT/TFE proteins act selectively in PDA cells to regulate a broad autophagy-lysosome program under basal conditions.
In non-transformed cells grown in nutrient-replete conditions, the MiT/TFE proteins are phosphorylated by mTORC1 at the lysosome membrane, leading to their interaction with 14-3-3 proteins and cytoplasmic retention, whereas mTORC1 inactivation upon starvation enables their nuclear translocation [9] [10] [11] . Correspondingly, HPDE and HPNE cells exhibited predominantly cytoplasmic residence of endogenous and ectopically expressed TFE3, MITF and TFEB under full nutrient conditions, and showed nuclear translocation after starvation or treatment with the mTOR inhibitor Torin 1 . In stark contrast, a series of PDA cell lines showed constitutive nuclear localization of each MiT/ TFE protein, regardless of nutrient status or treatment with Torin 1 or with inhibitors of MEK, another pathway implicated in their regulation 8 . Immunoblot for phospho-p70S6K, a readout of mTORC1 activity, and immunostaining for mTOR and LAMP2, indicated that mTORC1 was active and demonstrated amino-acid-regulated lysosomal association in PDA cells (Extended Data Fig. 3j, k) . In addition, all cells exhibited coimmunoprecipitation of TFE3 and MITF with 14-3-3 and loss of binding upon Torin 1 treatment, although the fractional binding in PDA cells was lower, consistent with the predominantly nuclear residence of the MiT/TFE proteins (Extended Data Fig. 3l ). Thus, PDA cells show constitutive MiT/TFE activation despite displaying intact mTORC1 signalling.
To uncover machinery that overrides cytoplasmic retention mechanisms, we employed affinity purification and quantitative proteomics 12 to identify PDA-specific TFE3-interacting proteins. Notably, importin 8 (IPO8), a member of the importin-b family of nucleocytoplasmic transporters 13, 14 , was significantly enriched in TFE3 immunoprecipitates in PDA cells but not in HPDE cells (Extended Data Fig. 4a ). We confirmed that Flag-tagged TFE3 bound endogenous IPO8 specifically in PDA cells (Fig. 2d and Extended Data Fig. 4b ). In addition, IPO8 was expressed at elevated levels in human PDA specimens and cell lines compared with controls ( Fig. 2e and Extended Data Fig. 4c, d ).
IPO8 and its most closely related homologue, IPO7, direct nuclear import of specific cargo, including growth regulatory proteins [14] [15] [16] [17] [18] [19] . Accordingly, IPO8 knockdown caused a marked decrease in nuclear TFE3 and reduced overall TFE3 protein levels in multiple PDA cell lines (Fig. 2f , left, and Extended Data Fig. 4e ). Similar effects were observed for both MITF and TFEB upon combined IPO8 and IPO7 knockdown (Fig. 2f, right, bottom and Extended Data Fig. 4f ). Importantly, in non-transformed HPDE and HPNE cells, IPO8 knockdown did not affect basal (cytoplasmic) TFE3 levels or Torin-1-induced nuclear translocation of TFE3 (Extended Data Fig. 4g, h ). Moreover, MiT/TFE mRNA levels were not significantly altered by IPO7/IPO8 inactivation (Extended Data Fig. 4i ). These findings suggest that importins may act selectively in PDA to regulate the stability of MiT/TFE proteins in addition to facilitating their nuclear transport. Indeed, cycloheximide treatment studies revealed that IPO8 knockdown accelerated TFE3 turnover in 8988T cells (Extended Data Fig. 4j ). Thus, IPO8-dependent nuclear accumulation of MiT/TFE factors results in their stabilization and upregulation of their transcriptional programs in PDA cells regardless of nutrient status.
We found that constitutive activation of MiT/TFE proteins was critical for autophagy-lysosome function in PDA cells. Depletion of MiT/TFE proteins across a series of PDA cell lines resulted in striking defects in lysosome morphology and increased lysosome diameter, (986.4 6 30.7 nm versus 2,722 6 72.6 nm for control siRNA (siCTRL) and siTFE3, respectively), effects commonly associated with lysosomal stress and defective proteolysis 20, 21 ( Fig. 2g and Extended Data Fig. 5a ), whereas HPDE cells were minimally affected (Extended Data Fig. 5b ). These responses were phenocopied by treatment of PDA cells with the vacuolar-type H 1 -ATPase inhibitor Bafilomycin A1 (BafA1) (Fig. 2g) . Correspondingly, transmission electron microscopy and TFE3  AGA  ARL8B  ARSA  ASAH1  ATG10  ATG14  ATG2B  ATP6V1C1  ATP6V1D  ATP6V1E1  ATP6V1G1  ATP6V1H  CLCN7  CLN3  CTSA  CTSS  CTSZ  GALC  GM2A  GNS  HEXB  HPS1  HPS4  MAP1LC3A  MCOLN1  NEU1  NPC2  SQSTM1  TPP1  ULK2  HPRT1  RPL18A  ACTB immunofluorescence microscopy of TFE3-knockdown cells revealed accumulation of autolysosomes containing undigested cargo ( Fig. 2h and Extended Data Fig. 5c, d ). Moreover, there was a pronounced increase in lysosomal pH as demonstrated using the pH-sensitive dye Oregon Green 514 coupled to dextran (Fig. 2i ). In addition, mCherry-GFP-LC3 autophagy reporter assays revealed that TFE3 inactivation decreased autophagic flux in 8988T cells (55.7 6 9.6% mCherry 1 /GFP 2 spots in siCTRL versus 19.8 6 2.9% in siTFE3; Fig. 2j ). Finally, to assay proteolytic activity, 8988T cells were fed boron-dipyrromethene (BODIPY)-dye-conjugated bovine serum albumin (BSA; DQ-BSA), which is taken up by macropinocytosis and fluoresces after proteolysis in lysosomes. TFE3 knockdown or BafA1 treatment resulted in dramatic decreases in fluorescent puncta co-localized with LAMP2 (14.8 6 6.1 spots per cell in siCTRL versus 3.7 6 1.8 and 0.2 6 0.7 spots per cell in siTFE3 and BafA1, respectively; Fig. 2k ). Tetramethylrhodamine (TMR)-dextran uptake was not affected, indicating specific impairment in lysosomal proteolysis rather than in internalization of extracellular cargo (data not shown). Notably, lysosomal breakdown of extracellular albumin scavenged through macropinocytosis is an important nutrient source in PDA
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. Thus, by governing both autophagic flux and lysosomal catabolism, the MiT/TFE proteins support an integrated cellular clearance program that enables efficient processing of cargo from autophagy as well as macropinocytosis, providing PDA cells with access to critical sources of both intracellular and extracellular nutrients.
MITF or TFE3 overexpression in pancreatic cells reinforced these findings, demonstrating induction of autophagy-lysosome genes, LC3B foci and lipidated LC3-II that was further enhanced after treatment with chloroquine, an inhibitor of lysosome acidification, indicating marked augmentation of autophagic flux (Extended Data Fig. 6a-e) .
Cargo degraded in the lysosome generates metabolic intermediates that may feed into multiple pathways 23, 24 . To obtain insight into the metabolic outputs of MiT/TFE-controlled autophagy-lysosome function, we conducted global metabolite profiling of 8988T and PSN1 cells transfected with TFE3-targeted siRNAs. These studies revealed statistically significant changes common to both cell lines in 15.2% (53/ 347) of detected metabolites. Most prominently altered were amino acids and their breakdown products, with 31% (25/80) showing decreased abundance, whereas only restricted changes were observed in other general metabolite groupings (Fig. 3a and Supplementary  Table 3 ). TFE3 silencing did not affect amino acid uptake (Extended Data Fig. 7a) , suggesting that the autophagy-lysosome system may supply a considerable fraction of intracellular amino acids irrespective of their external availability in PDA. In support of this model, TFE3 1 lysosomes for N 5 3 independent experiments with at least 50 cells scored per experiment). **P , 0.0001. Scale bars: 18 mm (a, b); 50 mm (e); 7.5 mm (g). Significance was analysed using twotailed Student's t-test. 
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knockdown, BafA1 treatment, and inactivation of autophagy by ATG5 knockdown significantly decreased intracellular amino acid levels in PDA cell lines but not in control cells (Fig. 3b, , and led to activation of AMP-activated protein kinase (AMPK) and decreased cellular ATP levels, suggesting induction of energy stress (Extended Data Fig. 8a-c) . Reciprocally, overexpression of MITF or TFE3 in HDPE cells caused downregulation of AMPK signalling (Extended Data Fig. 8d ).
These findings imply that PDA cells should have increased capacity to buffer amino acid levels under conditions of nutrient deprivation. To test this, we switched cells to low amino acid concentration media (10% of normal) and monitored phosphorylation of p70S6K, a readout of mTORC1 activity that is sensitive to fluctuations in intracellular amino acid levels 25 . HPDE cells showed extinction of phosphorylated (p)-p70S6K within 5-15 min in 10% amino acid media, whereas PDA cells (8988T and PSN1) maintained robust levels for .30 min (Fig. 3d) . Correspondingly, TFE3 inactivation in 8988T cells greatly accelerated the decline in p-p70S6K (Fig. 3e) . Reciprocally, MITF overexpression in HPDE cells caused p-p70S6K levels to be sustained upon 10% amino acid starvation, and markedly increased clonogenic growth in this setting while not affecting clonogenicity in full nutrients (Fig. 3f,  g ). Taken together, these data indicate that PDA cells rely on autophagy-lysosome function for maintenance of intracellular amino acid pools, which facilitates survival in response to nutrient stress.
Consistent with key roles of MiT/TFE proteins in organelle function and metabolic regulation, the growth of PDA cell lines expressing high endogenous levels of MITF, TFE3 or TFEB was significantly impaired by knockdown of the relevant factor, an effect rescued by co-expression of short hairpin RNA (shRNA)-resistant cDNAs (Fig. 4a, b and Extended Data Fig. 9a ). By contrast, the growth of HPNE and QGP1 cells was unaffected (Extended Data Fig. 9a ). As previously reported, PDA cells were broadly sensitive to chloroquine treatment compared with control cells 2 (Extended Data Fig. 9b ). Moreover, ectopic expression of MITF or TFE3 rendered HPNE cells hypersensitive to chloroquine, linking MiT/TFE-regulated clearance pathways to these growth phenotypes (Fig. 4c) . To extend our findings in primary patient-derived samples, we examined a series of early passage PDA cultures. Importantly, these cells also showed high basal autophagy, nuclear-localized MiT/ TFE proteins, and MiT/TFE-dependent autophagy-lysosome gene expression, organelle function, and colony-forming ability (Extended Data Fig. 9c-g ).
Notably, knockdown of TFE3 and MITF virtually abolished xenograft tumour growth of Panc1 and 8988T cells, and PL18 cells, respectively ( Fig. 4d and Extended Data Fig. 9h ). Conversely, MITF overexpression enhanced the tumorigenicity of primary Kras G12D -expressing mouse pancreatic epithelial cells. Whereas Kras G12D control cells formed only focal low-grade pancreatic intraepithelial neoplasia (PanIN)-like lesions by 6 weeks after orthotopic injection, co-expression of MITF resulted in large invasive tumours in 3/5 mice ( Fig. 4e and Extended Data Fig. 9i ). Thus, in keeping with their requirement for augmenting autophagy-lysosome function, MiT/TFE proteins are potent drivers of PDA pathogenesis in vivo.
Our work places a new focus on lysosome regulation by MiT/TFE proteins as a nexus for metabolic reprogramming in PDA cells. Increased lysosome activity integrates major routes for nutrient scavenging-autophagy and macropinocytosis-thereby maintaining intracellular amino acid availability (Fig. 4f) . Escape of MiT/TFE factors from inhibition by mTORC1 enables cancer cells to maintain robust activation of anabolic pathways while simultaneously benefiting from the metabolic fine-tuning and adaptation to stress afforded by activation of autophagy and lysosomal catabolism. Thus, we propose that lysosome activation under the control of the MiT/TFE transcriptional program is a novel hallmark of PDA. These findings, together with recent work [26] [27] [28] , suggest that targeting aberrant lysosomal function has a potential therapeutic benefit in cancer. Significance was analysed using two-tailed Student's t-test.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Error bars indicate mean 6 s.d. for N 5 3 independent experiments; *P , 0.005, **P , 0.0001. d, TFE3 knockdown with two independent shRNAs significantly impairs subcutaneous xenograft growth of Panc1 cells. Error bars indicate mean 6 s.e.m. for N 5 6 tumours per group; *P , 0.03. e, MITF overexpression in Kras G12D mouse PanIN cells promotes tumorigenesis upon orthotopic injection. N 5 5 mice per group; **P , 0.001. Scale bar, 200 mm. f, In PDA, the MiT/TFE proteins are upregulated and exhibit increased nuclear residence due to IPO8/IPO7-mediated trafficking, leading to transcriptional induction of autophagy-lysosome genes and increased biogenesis and function of these organelles. Autophagy-lysosome expansion integrates two major pathways for nutrient scavenging and metabolic adaptation in PDA, autophagy and digestion of serum proteins obtained by macropinocytosis. . Negative mycoplasma contamination status of all cell lines and primary cells used in the study was established using LookOut Mycoplasma PCR Kit (Sigma, MP0035). Constructs. N-terminal Flag-tagged human MITF-H isoform expression constructs were generated by subcloning the cDNA of MITF-H (Origene) into the NheI and EcoRI sites of the pLJM1 (Addgene) lentiviral vector, the NotI and EcoRI sites of the pRetroX-Tight-Pur (Clonetech) doxycycline-inducible vector or the EcoRI and SalI sites of the pBabe-puro retroviral vector. Dominant-negative MITF-H isoform lacking the 59 transactivation domain was generated as previously described for the MITF-M isoform 30 . Briefly, the first 280 amino acids corresponding to 840 bp was deleted followed by deletion of R301 (corresponding to R218 of MITF-M). This cDNA was cloned into the NheI and EcoR1 sites of pLJM1. N-terminal Flag-tagged full-length human TFE3 expression constructs were generated by subcloning the cDNA of TFE3 from pcDNA3.1-(HA) 2 -TFE3 (obtained from D. Fisher) into the BamHI and EcoRI sites of the pBabe-puro retroviral vector. GFP-tagged MITF and TFE3 were generated by subcloning the cDNA of MITF-H into BglII and SalI sites and TFE3 into HindIII and BamHI sites of the pEGFP-C1 (Clonetech) vector. siRNA-resistant expression constructs of MITF and TFE3 were generated via QuikChange Site-Directed Mutagenesis (Agilent Technologies). mCherry-GFP-LC3 was a gift from A. Kimmelman. siRNA and lentiviral-mediated shRNA targets. siRNAs against MITF, TFE3, TFEB, ATG5 and IPO8 were purchased from Ambion and Thermo Scientific. The RNAi Consortium clone IDs for the shRNAs used in this study are as follows: shMITF, TRCN0000329793 (CGGGAAACTTGATTGATCTTT), TRCN0 000019122 (CGTGGACTATATCCGAAAGTT); shTFEB, TRCN0000013108 (CCCACTTTGGTGCTAATAGCT), TRCN0000013109 (CGATGTCCTT GGCTACATCAA). shRNA constructs against human TFE3 were generated by annealing oligonucleotides against human TFE3 (corresponding to the sequence of the siRNA described later) into the AgeI and EcoRI sites of pLKO.1-puro vector. TFE3 target sequences are the following: GCAGCTCCGAATTCAGGAACT; CGCAGGCGATTCAACATTAAC; GGAATCTGCTTGATGTGTACA. Cell proliferation and colony formation assay. Cells were plated in 12-well plates at 30,000 cells per well in 2 ml of complete culture media or in 6-well plates at 2,000 cells per well in 2 ml of media. At the indicated time points, cells were trypsinized and counted. Colony plates were fixed 7 days post-plating in 4% paraformaldehyde and stained with 0.1% crystal violet. Amino acid starvation and BafA1 treatment. Ten per cent amino acid (AA) starvation was conducted by incubating cells in AA-free RMPI supplemented with 10 mM glucose, and 10% AA calculated relative to levels present in RPMI media. Stock solutions of AA were made from individual powders. Where BafA1 treatment was performed, cells were incubated with 150 nM BafA1. Acute AA starvation during colony formation was conducted by incubating cells in AA-free media for 18 h on day 2 post-plating. Media was then changed to complete growth media for an additional 6 days of cell growth. SDS-PAGE analysis. Cells were lysed in ice-cold lysis buffer (150 mM NaCl, 20 mM Tris (pH 7.5), 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pryophosphate, 1 mM b-glycerophosphate, 1 mM sodium vanadate, and one tablet of EDTA-free protease inhibitors (Roche) per 10 ml). Samples were clarified by centrifugation and protein content measured using BCA protein assay kit (Thermo Scientific). Thirty milligrams of protein was resolved on 9% SDS-PAGE gels and transferred onto PVDF membranes (GE Healthcare Life Sciences). Membranes were blocked in Tris-buffered saline (TBS) containing 5% non-fat dry milk and 0.1% Tween 20 (TBS-T), before incubation with primary antibody overnight at 4 uC. The membranes were then washed with TBS-T followed by exposure to the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody for 45 min and visualized on Kodak X-ray film using the enhanced chemiluminescence (ECL) detection system (Thermo Scientific). Subcellular fractionation was performed using the Thermo Scientific NE-PER nuclear and cytoplasmic fractionation kit according to the manufacturer's procedures. For immunoprecipitation experiments, 1-3 mg of clarified protein lysate from cell lines stably expressing Flag-tagged MiT/TFE proteins was captured on anti-Flag antibody-conjugated protein A-agarose beads (M2-Flag affinity gel; Sigma-Aldrich). Immune complexes were washed and analysed via SDS-PAGE and western blotting. Immunoglobulin G antibody was used as a control. Metabolite extraction. Samples were extracted while cells were in the exponential growth phase. Wells were washed with 13 PBS and aspirated. Six-hundred microlitres of 280 uC MeOH:H 2 O (50:50) was added to each well and the plate was then placed at 280 uC for 1-1.5 h. As plates were thawing on ice, cells were detached by scraping and transferred to a 1.5 ml tube and placed on dry ice. Samples were vortexed at 4 uC for 30 s. To clarify homogenates, samples were centrifuged at 20,000g, for 7 min at 4 uC. Clarified supernatants were transferred to new 1.5 ml tubes. Six-hundred microlitres of choloroform (stabilized with amylene) was added to each sample, one at a time, and the sample was immediately vortexed at room temperature for 30 s, and then placed on ice. Phase separation was achieved by centrifugation at 20,000g, for 0.25 h at 4 uC. The aqueous (polar) phase was extracted and transferred to a fresh 1.5 ml tube. The samples were evaporated by SpeedVac, snap frozen in liquid nitrogen, and stored at 280 uC for further processing. Derivatization (all samples). Evaporated samples were warmed to room temperature by quickly spinning them in a SpeedVac. Samples were dissolved in 30 ml of 2% methoxyamine hydrochloride in pyridine (MOX) (Pierce) at 37 uC for 1.5 h. Samples were derivatized by adding 45 ml of N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MBTSTFA) 1 1% tert-butyldimethylchlorosilane (TBDMCS; Pierce) at 60 uC for 1 h. Gas chromatography-tandem mass spectrometry analysis. Gas chromatography-mass spectrometry (GC-MS) analysis was performed as described 31, 32 . Briefly, analysis was performed on an Agilent 6890 GC instrument that contained a 30 m DB-35MS capillary column, which was interfaced to an Agilent 5975B MS. Electron impact (EI) ionization was set at 70 eV. Each analysis was operated in scanning mode, recording mass-to-charge-ratio spectra in the range of 100-605 m/z. For each sample, 1 ml was injected at 270 uC, using helium as the carrier gas at a flow rate of 1 ml min
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. To mobilize metabolites, the GC oven temperature was held at 100 uC for 3 min and increased to 300 uC at 3.5 uC min
. Samples were analysed in triplicate. Metabolite levels where normalized to cell number and/or protein and plotted as fold change relative to control conditions. Immunofluorescence assays. Cells were plated on fibronectin-coated glass coverslips at 100,000-300,000 cells per coverslip. Twelve-to-sixteen hours later, the slides were rinsed with PBS once and fixed for 15 min with 4% paraformaldehyde at room temperature or for 5 min with 220 uC methanol. The slides were rinsed twice with PBS and cells were permeabilized with 0.05% Triton X-100 for 2 min. After rinsing twice with PBS, the slides were incubated with primary antibody in 5% normal goat serum for 1 h at room temperature, rinsed four times with PBS, and incubated with secondary antibodies produced in goat (diluted 1:400 in 5% normal goat serum) for 45 min at room temperature in the dark. Slides were mounted on glass slides using Vectashield (Vector Laboratories) and imaged on a spinning disk confocal system (Perkin Elmer) or a Zeiss Laser Scanning Microscope (LSM) 710. Images were processed using ImageJ and Adobe PhotoshopCS4. For quantification of lysosome diameter, ImageJ software was used to draw lines across 130-290 lysosomes from 3-5 fields containing 4-6 cells per field. Line pixel values were converted into mm based on objective magnification and camera pixel size. Presented data are representative of 3-5 replicate experiments. DQ-BSA experiments were performed as previously described 33 . Briefly, cells were incubated with DQ-BSA for 30 min and subsequently chased for 1 h in DQ-BSA-free media. Where indicated, treatment with BafA1 was for 1 h at 100 nM. The number of DQ-BSA spots co-localizing with LAMP2-positive lysosomes was counted. Measurement of autolysosome maturation was performed in cells transfected with the mCherry-GFP-LC3 reporter. Cells were transfected with siCTRL or siMITF/siTFE3 and 48 h later transfected with the mCherry-GFP-LC3. After 24 h, cells were fixed in 4% PFA and quantification of total number of autolysosomes (mCherry 1 /GFP 2 spots) compared to total spots per cell (N . 1,000 total spots from N 5 10 cells per condition) for at least three independent experiments was counted.
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Histology and immunostaining. Tissue samples were fixed overnight in 4% buffered formaldehyde, and then embedded in paraffin and sectioned (5 mm thickness) by the DF/HCC Research Pathology Core. Haematoxylin and eosin staining was performed using standard methods. For immunohistochemistry, unstained slides were baked at 55 uC overnight, deparaffinized in xylenes (two treatments, 6 min each), rehydrated sequentially in ethanol (5 min in 100%, 3 min in 95%, 3 min in 75%, and 3 min in 40%), and washed for 5 min in 0.3% Triton X-100/PBS (PBST) and 3 min in water. For antigen unmasking, specimens were cooked in a 2100 Antigen Retriever (Aptum Biologics) in 13 Antigen Unmasking Solution, Citric Acid Based (H-3300, Vector Laboratories), rinsed three times with PBST, incubated for 10 min with 1% H 2 O 2 at room temperature to block endogenous peroxidase activity, washed three times with PBST, and blocked with 5% goat serum in PBST for 1 h. Primary antibodies were diluted in blocking solution as follows: anti-TFE3 (Cell Marque, 354R-14) 1:100; anti-CTSS (Sigma, HPA002988) 1:200; anti-ATP6V1H (Sigma, HPA023421) 1:100; anti-ULK2 (Sigma, HPA009027) 1:100, and incubated with the tissue sections at 4 uC overnight. The evaluation of MITF and TFEB protein levels in patient PDA tissue could not be evaluated due to lack of antibodies suitable for immunohistochemistry (IHC). Commercially available MITF antibodies for IHC are specific to the melanoma (MITF-M) isoform or cross-react with other MiT/TFE family members. Specimens were then washed three times for 3 min each in PBST and incubated with biotinylated secondary antibody (Vector Laboratories) in blocking solution for 1 h at room temperature. Specimens were then washed three times in PBST and treated with ABC reagent (Vectastain ABC kit #PK-6100) for 30 min, followed by three washes for 3 min each. Finally, slides were stained for peroxidase for 3 min with the DAB (diaminebenzidine) substrate kit (SK-4100, Vector Laboratories), washed with water and counterstained with haematoxylin. Immunostaining was assessed by semi-quantitative analysis of tissue microarray, quantifying the intensity of stained tumour cells scored on a scale from 0 (no staining) to 3 (strongest intensity). Stained slides were photographed with an OlympusDP72 microscope.
For human samples, PDA samples used for IHC and generation of early passage PDA cultures were obtained under IRB-approved protocols 02-240 and 2007P001918. The samples for IHC were from patients resected at MGH between 2001 and 2012. Pathological diagnosis of PDA was confirmed by a gastrointestinal cancer pathologist at MGH (V.D.). Early passage PDA cultures were derived from ascites specimens. Patients were verified to have PDA from biopsies. Electron microscopy. For in vitro studies, tissue culture specimens in confluent 6-well or 10-cm plates were fixed directly with gentle rocking for 15 min at room temperature with a glutaraldehyde fixative (2.5% glutaraldehyde, 2% paraformaldehyde, 0.025% calcium chloride, in a 0.1 M sodium cacodylate buffer, pH 7.4), gently scraped and pelleted at 500g, and washed twice with cacodylate buffer. To make a cell block, the cells were centrifuged and resuspended in warm (60 uC) 2% agar in a warm water bath to keep the agar fluid. The cells were then centrifuged again and the agar allowed to harden in an ice water bath. The tissuecontaining tip of the centrifuge tube was cut off, resulting in an agar block with the cells embedded within it. This agar block was subsequent routinely processed in a Leica Lynx automatic tissue processor. Briefly, the tissue was post-fixed in osmium tetroxide, stained en bloc with uranyl acetate, dehydrated in graded ethanol solutions, infiltrated with propylene oxide/Epon mixtures, embedded in pure Epon, and polymerized overnight at 60 uC. One-micrometre sections were cut, stained with toluidine blue, and examined by light microscopy. Representative areas were chosen for electron microscopic study and the Epon blocks trimmed accordingly. Thin sections were cut with an LKB 8801 ultramicrotome and diamond knife, stained with lead citrate, and examined in a FEI Morgagni transmission electron microscope. Images were captured with an AMT digital CCD camera.
For analysis of human tissue, fresh biopsy tissue placed into Karnovsky's KII Solution (2.5% glutaraldehyde, 2.0% paraformaldehyde, 0.025% calcium chloride, in a 0.1 M sodium cacodylate buffer, pH 7.4), fixed overnight at 4 uC, and stored in cold buffer. Subsequently, they were post-fixed in osmium tetroxide, stained en bloc with uranyl acetate, dehydrated in graded ethanol solutions, infiltrated with propylene oxide/Epon mixtures, flat embedded in pure Epon, and polymerized overnight at 60 uC. One-micrometre sections were cut, stained with toluidine blue, and examined by light microscopy. Representative areas were chosen for electron microscopic study and the Epon blocks were trimmed accordingly. Thin sections were cut with an LKB 8801 ultramicrotome and diamond knife, stained with Sato's lead, and examined in a FEI Morgagni transmission electron microscope. Images were captured with an Advanced Microscopy Techniques 2K digital CCD camera. Measurement of lysosomal pH. Determination of lysosomal pH was carried out on intact cells by ratiometric imaging of the pH-sensitive dye Oregon Green 514, as described 34, 35 . 8988T cells were transfected with control siRNA or TFE3 siRNA. One day before the experiment, 80,000 cells were plated in black 96-multiwell plates in low serum and low glucose media. On the day of the experiment, cells were fed 30 mg ml 21 70 kDa dextran conjugated to Oregon Green 514 (Dx-OG514, Invitrogen) for 6 h in full media. Cells were rinsed three times to remove excess dye, and chased for 2 h in media free of Dx-OG514, which results in the selective accumulation of Dx-OG514 in lysosomes. Dx-OG514 fluorescence was collected at 530 nm upon excitation at 440 nm and 490 nm in a Spectramax microplate reader (Molecular Devices). The 490/440 fluorescence emission ratios were interpolated to a calibration curve. The calibration curve was built by bathing cells in a K 1 isotonic solution (145 mM KCl, 10 mM glucose, 1 mM MgCl 2 , and 20 mM of either HEPES, MES, or acetate) buffered to pH ranging from 3.5 to 7.0 and containing 10 mg ml 21 Nigericin. The 490/440 ratios were plotted as a function of pH, and fitted to a Boltzmann sigmoid. All measurements were performed in quadruplicate. Presented data are representative of 3 replicate experiments. Quantitative RT-PCR. Total cellular RNA was extracted using RNeasy Mini Kit (Qiagen) and reverse transcription was performed from 2 mg of total RNA using the QuantiTect Reverse Transcription Kit (Qiagen). Quantitative RT-PCR was performed with FastStart Universal SYBR Green (Roche) in a MX3005P continuous fluorescence detector (Stratagene) or using a Lightcycler 480 (Roche). PCR reactions were performed in triplicate and the relative amount of cDNA was calculated by the comparative CT method using the 18S ribosomal RNA sequences as a control. Primer sequences are available upon request. MITF isoform-specific PCR was conducted as previously described 36 . ChIP. ChIP experiments were conducted using the Chromatin Immunoprecipitation assay kit (Millipore) according to the manufacturer's instructions. Briefly, 10 6 cells expressing Flag-tagged MITF or TFE3 were fixed with 1% formaldehyde for 10 min (for Flag-MITF experiments, cells were fixed 48 h after doxycycline treatment). Cells were washed twice with ice-cold PBS and lysed in ice-cold SDS lysis buffer containing protease inhibitors (Roche). Chromatin extraction and DNA sonication were conducted according to the manufacturer's protocol. DNA was recovered from immune complexes on M2-Flag affinity gel. The immuno-precipitated DNA was recovered and analysed by real-time PCR. ChIP primers have been previously described 37 . Xenograft studies. Mice were housed in pathogen-free animal facilities. All experiments were conducted under protocol 2005N000148 approved by the Subcommittee on Research Animal Care at Massachusetts General Hospital. For subcutaneous xenografts, Panc1, 8988T or PL18 cells were infected with lentiviral shRNAs targeting TFE3 (n 5 2), MITF (n 5 2) and GFP (control hairpin, n 5 1) and subjected to a puromycin selection (2 mg ml 21 ) in vitro. 1.5-2.5 3 10 6 cells, suspended in a 1:1 mixture of HBSS:matrigel, were injected subcutaneously into the lower flank of 3-4 female NOD.CB17-Prkdcscid/J mice per group (6-10 weeks of age) (purchase from Jackson Laboratories, strain #001303). Tumour length and width were measured weekly and the volume was calculated according to the formula (length 3 width 2 )/2. All xenograft experiments with human PDA lines were approved by the HMS Institutional Animal Care and Use Committee (IACUC) under protocol number 04-605. For orthotopic mouse studies, MITF or GFP was stably expressed in mouse PanIN primary cells 38 . Alternatively, a doxycycline-inducible expression construct for MITF was also stably expressed in mouse PanIN primary cells. 1 3 10 6 cells were orthotopically injected in a 1:1 mixture of matrigel:PBS into the pancreas of SCID mice (n 5 5 per group). Mice were euthanized 6 weeks after implantation, pancreas were collected and submitted for histological examination. No mice were excluded from the analysis. Experiments were designed to detect a 50% change in tumour size with 80% power and a type I error of 5% using the t-test. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Image analysis and statistics. Image analysis, including densitometry and measurement of fluorescence intensity, was conducted using Image J software (NIH). Statistical analyses of results are expressed as mean 6 standard deviation, unless otherwise specified. Significance was analysed using two-tailed Student's t-test. A P value of less than 0.05 was considered statistically significant. Gene expression profiling and GSEA. To build a comprehensive autophagylysosome gene signature (gene set), we combined published lysosome proteomics 39,40 and autophagy interactome data sets 41 together with known lysosomal disease associated genes 42 (see Supplementary Table 1) . Data sets used for the meta-analysis in Fig. 1c, f and Extended Data Fig. 1b, c are accessible from the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/gds/), including GSE16515, GSE28735 and GSE15471, from The Cancer Genome Atlas (TCGA; http://cancergenome.nih.gov/), from the Cancer Cell Line Encyclopedia (CCLE; http://www.broadinstitute.org/software/cprg/?q5node/11). For the GEO and CCLE data sets, raw expression values in the form of CEL files were collected and then processed using RMA in the R bioconductor package. For TCGA data, expression data sets were created by combining RNASeqV2 Level3 normalized gene result files for individual samples and producing tables with genes in rows and samples in columns. Data for the 8988T cells of Fig. 1g , h was processed using LETTER RESEARCH a standard RNA-seq pipeline that used Trimmomatic to clip and trim the reads, used tophat2 to align the reads to hg19, and used cuffdiff to calculate differential expression. GSEA (http://www.broadinstitute.org/gsea/index.jsp) of the expression data was used to assess enrichment of the autophagy-lysosome gene signature. Depending upon the data set, there were several different methods used to rank genes for GSEA. In the PDA samples for Fig. 1f and Extended Data Fig. 1i , j genes were ranked according to Pearson correlation with a meta-gene formed by the mean expression of MITF, TFE3 and TFEB, and P values were obtained by permuting the phenotype (2,500 permutations). In the 8988T cells of Fig. 1g , h, a pairwise GSEA was performed by creating ranked lists of genes using the log 2 ratio of siTFE3 to siCTRL, and P values were obtained by permuting the gene set (1,000 permutations). In the paired tumour/normal PDA data sets of Extended Data Fig.  1b , a paired t-test between matched tumour-normal samples was used to rank genes and the ranked list was used in GSEA with P values from permuting the gene set (2,500 permutations). For Extended Data Fig. 1k , Database for Annotation, Visualization and Integrated Discovery (DAVID) analysis of PDA cell lines in CCLE was performed as described 43 by using Pearson correlation to select the 100 genes most correlated with TFE3 and MITF, and checking for enriched pathways. Quantitative proteomics on TFE3-associated proteins. Enriched proteins were subjected to multiplexed quantitative proteomics analysis using tandem-mass tag (TMT) reagents on an Orbitrap Fusion mass spectrometer (Thermo Scientific). Disulfide bonds were reduced with ditheiothreitol (DTT) and free thiols alkylated with iodoacetamide as described previously 44 . Proteins were then precipitated with tricholoracetic acid, resuspended in 50 mM HEPES (pH 8.5) and 1 M urea and digested first with endoproteinase Lys-C (Wako) for 17 h at room temperature and then with sequencing-grade trypsin (Promega) for 6 h at 37 uC. Peptides were desalted over Sep-Pak C 18 solid-phase extraction (SPE) cartridges (Waters), the peptide concentration was determined using a BCA assay (Thermo Scientific) and a maximum of 50 mg of peptides were labelled with one out of the available TMT10plex reagents (Thermo Scientific) 45 . To achieve this, peptides were dried and resuspended in 50 ml of 200 mM HEPES (pH 8.5) and 30% acetonitrile (ACN) and 10 mg of the TMT in reagent in 5 ml of anhydrous ACN was added to the solution, which was incubated at room temperature for 1 h. The reaction was then quenched by adding 6 ml of 5% (w/v) hydroxylamine in 200 mM HEPES (pH 8.5) and incubation for 15 min at room temperature. The solutions were acidified by adding 50 ml of 1% trifluoroacetic acid (TFA) and samples that were quantified in one mass spectrometry measurement were pooled before being subjected to desalting over a Sep-Pak C 18 (SPE) cartridge. The peptide mixtures were then dried and resuspended in 8 ml, three of which were analysed by microcapillary liquid chromatography tandem mass spectrometry on an Orbitrap Fusion mass spectrometer and using a recently introduced multistage (MS3) method to provide highly accurate quantification 44, 45 . The mass spectrometer was equipped with an EASY-nLC 1000 integrated autosampler and HPLC pump system. Peptides were separated over a 100 mm inner diameter microcapillary column in-house packed with first 0.5 cm of Magic C4 resin (5 mm, 100 Å , Michrom Bioresources), then with 0.5 cm of Maccel C 18 resin (3 mm, 200 Å , Nest Group) and 29 cm of GP-C18 resin (1.8 mm, 120 Å , Sepax Technologies). Peptides were eluted applying a gradient of 8-27% ACN in 0.125% formic acid over 165 min at a flow rate of 300 nl min
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. To identify and quantify the TMT-labelled peptides we applied a synchronous precursor selection MS3 method [44] [45] [46] in a data-dependent mode. The scan sequence was started with the acquisition of a full MS or MS1 one spectrum acquired in the Orbitrap (m/z range, 500-1,200; resolution, 60,000; AGC target, 5 3 10 5 ; maximum injection time, 100 ms), and the ten most intense peptide ions from detected in the full MS spectrum were then subjected to MS2 and MS3 analysis, while the acquisition time was optimized in an automated fashion (top speed, 5 s). MS2 scans were done in the linear ion trap using the following settings: quadrupole isolation at an isolation width of 0.5 Th; fragmentation method, CID; AGC target, 1 3 10 4 ; maximum injection time, 35 ms; normalized collision energy, 30%). Using synchronous precursor selection the ten most abundant fragment ions were selected for the MS3 experiment following each MS2 scan. The fragment ions were further fragmented using the HCD fragmentation (normalized collision energy, 50%) and the MS3 spectrum was acquired in the Orbitrap (resolution, 60,000; AGC target, 5 3 10 4 ; maximum injection time, 250 ms). Data analysis was performed on an on an in-house generated SEQUESTbased 47 software platform. RAW files were converted into the mzXML format using a modified version of ReAdW.exe. MS2 spectra were searched against a protein sequence database containing all protein sequences in the human UniProt database (downloaded 4 February 2014) as well as that of known contaminants such as porcine trypsin. This target component of the database was followed by a decoy component containing the same protein sequences but in flipped (or reversed) order 48 . MS2 spectra were matched against peptide sequences with both termini consistent with trypsin specificity and allowing two missed trypsin cleavages. The precursor ion m/z tolerance was set to 50 p.p.m., TMT tags on the N terminus and on lysine residues (229.162932 Da) as well as carbamidomethylation (57.021464 Da) on cysteine residues were set as static modification, and oxidation (15.994915 Da) of methionines as variable modification. Using the target-decoy database search strategy 48 a spectra assignment false discovery rate of less than 1% was achieved through using linear discriminant analysis with a single discriminant score calculated from the following SEQUEST search score and peptide sequence properties: mass deviation, XCorr, dCn, number of missed trypsin cleavages, and peptide length 49 . The probability of a peptide assignment to be correct was calculated using a posterior error histogram and the probabilities for all peptides assigned to a protein were combined to filter the data set for a protein FDR of less than 1%. Peptides with sequences that were contained in more than one protein sequence from the UniProt database were assigned to the protein with most matching peptides 49 . TMT reporter ion intensities were extracted as that of the most intense ion within a 0.03 Th window around the predicted reporter ion intensities in the collected MS3 spectra. Only MS3 with an average signal-to-noise value of larger than 28 per reporter ion as well as with an isolation specificity 44 of larger than 0.75 were considered for quantification. Reporter ions from all peptides assigned to a protein were summed to define the protein intensity. A two-step normalization of the protein TMT intensities was performed by first normalizing the protein intensities over all acquired TMT channels for each protein based to the median average protein intensity calculated for all proteins. To correct for slight mixing errors of the peptide mixture from each sample a median of the normalized intensities was calculated from all protein intensities in each TMT channel and the protein intensities were normalized to the median value of these median intensities. RESEARCH LETTER
